Free Trial
CVE:NDVA

Indiva (NDVA) Stock Price, News & Analysis

Indiva logo
C$0.03 -0.01 (-14.29%)
As of 06/12/2024

About Indiva Stock (CVE:NDVA)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.13
Volume
558,384 shs
Average Volume
119,038 shs
Market Capitalization
C$5.86 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

NDVA Stock News Headlines

Indiva Ltd Average Daily Volume (3m)
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Indiva Limited (NDVA-H.V)
NDVA:CA Indiva Limited
Indiva Limited (NDVAF) Q4 2023 Earnings Call Transcript
See More Headlines

NDVA Stock Analysis - Frequently Asked Questions

Indiva's stock was trading at C$0.03 at the start of the year. Since then, NDVA shares have increased by 0.0% and is now trading at C$0.03.

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:NDVA
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.92 million
Net Margins
-13.09%
Pretax Margin
N/A
Return on Equity
-544.76%
Return on Assets
-3.51%

Debt

Debt-to-Equity Ratio
5,899.22
Current Ratio
0.72
Quick Ratio
0.52

Sales & Book Value

Annual Sales
C$37.57 million
Price / Sales
0.16
Cash Flow
C$0.01 per share
Price / Cash Flow
5.20
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
195,490,000
Free Float
N/A
Market Cap
C$5.86 million
Optionable
Not Optionable
Beta
1.12
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (CVE:NDVA) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners